{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:5077c19f-03bf-42d4-b235-b14209063743", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-09-21T04:04:56.099873Z", "firstcreated": "2026-09-21T04:01:34.131088Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "Sanidad deja sin financiación pública los dos fármacos que frenan el Alzheimer en fase inicial", "byline": "Iván Serrano", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Evolut", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "La Comisión Interministerial de Precios de los Medicamentos rechaza incluir en el Sistema Nacional de Salud dos tratamientos aprobados por la EMA que ralentizan el deterioro cognitivo. La SEN advierte de que la decisión limita el acceso a quienes puedan pagarlos en la sanidad privada.", "altids": {"mosaic": "5077c19f-03bf-42d4-b235-b14209063743", "story": "d1cf5b4d-51bb-4976-be73-4ad5166ff361", "slug": "sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "La Comisión Interministerial de Precios de los Medicamentos rechaza incluir en el Sistema Nacional de Salud dos tratamientos aprobados por la EMA que ralentizan el deterioro cognitivo. La SEN advierte de que la decisión limita el acceso a quienes puedan pagarlos en la sanidad pri", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:0ca07266-8cdc-4158-aca5-79baacc6b391", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Sanidad deja a los pacientes de Alzheimer sin acceso público a dos tratamientos ya aprobados en la UE", "description_text": "Sanidad deja sin financiación pública los dos fármacos que frenan el Alzheimer en fase inicial", "copyrightholder": "okdiario.com", "copyrightnotice": "Sanidad deja a los pacientes de Alzheimer sin acceso público a dos tratamientos ya aprobados en la UE", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "0ca07266-8cdc-4158-aca5-79baacc6b391"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-09-21T04:04:56.119097Z", "attribution_required": true, "attribution_text": "Sanidad deja a los pacientes de Alzheimer sin acceso público a dos tratamientos ya aprobados en la UE", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "okdiario.com", "source_url": "https://okdiario.com/img/2026/09/18/ad.jpg", "source_page_url": "https://okdiario.com/img/2026/09/18/ad.jpg", "our_page_url": "https://evolut.top/sociedad/sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://okdiario.com/img/2026/09/18/ad.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:d1cf5b4d-51bb-4976-be73-4ad5166ff361", "slug": "sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial-20260921", "status": "developing", "languages": ["es"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Evolut", "canonical_required": true, "canonical_url": "https://evolut.top/sociedad/sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.903, "checked_at": "2026-09-21T04:04:56.116336Z"}}, "wireva:publication": {"name": "Evolut", "domain": "evolut.top", "country": "ES", "url": "https://evolut.top/sociedad/sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/5077c19f-03bf-42d4-b235-b14209063743", "html": "https://wireva.mib.news/item/5077c19f-03bf-42d4-b235-b14209063743/sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial/", "story": "https://wireva.mib.news/story/sanidad-deja-sin-financiacion-publica-los-dos-farmacos-que-frenan-el-alzheimer-en-fase-inicial-20260921/"}, "wireva:metrics": {"word_count": 751, "char_count": 4657, "reading_time_seconds": 333}}}